Skip to main content
BICO Group logo

BICO Group — Investor Relations & Filings

Ticker · BICO ISIN · SE0013647385 LEI · 549300FE4PT8NDXXNK85 ST Manufacturing
Open in API
Filings indexed 239 across all filing types
Latest filing 2021-05-19 M&A Activity
Country SE Sweden
Listing ST BICO

About BICO Group

http://bico.com

BICO Group is a bioconvergence company that provides technologies and solutions for laboratory automation in the life sciences. Integrating biology, engineering, and digital technologies, the company aims to accelerate innovation and automate the lab of the future. BICO offers a portfolio of hardware, software, and services across two business areas: Lab Automation and Life Science Solutions. Its products, including bioprinting technologies, are designed to enhance research efficiency and accuracy for pharmaceutical and biotechnology clients. By automating labor-intensive tasks, the solutions generate standardized, high-quality data, which supports data-driven decision-making and the application of artificial intelligence and machine learning in research and development.

Recent filings

Filing Released Lang Actions
CELLINK has entered into an agreement to acquire Nanoscribe, a market leading 3D bioprinting company based on Two-Photon Polymerization technology
M&A Activity Classification · 1% confidence The document is a press release dated May 19, 2021, announcing that CELLINK AB has entered into an agreement to acquire Nanoscribe. This announcement details the terms of the transaction (purchase price, earn-outs, share issuance), strategic rationale, and expected consolidation timeline. This type of announcement regarding a significant corporate transaction (Merger or Acquisition) fits the definition of M&A Activity (TAR). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it specifically concerns a takeover/acquisition proposal.
2021-05-19 English
CELLINK har ingått avtal om att förvärva Nanoscribe, ett marknadsledande bolag inom 3D bioprintning baserad på 2PP-teknik (Two-Photon Polymerization)
M&A Activity Classification · 1% confidence The document is a press release dated May 19, 2021, announcing that CELLINK AB has entered into an agreement to acquire Nanoscribe Holding GmbH. The text details the transaction structure, purchase price (34 million EUR plus contingent consideration), payment method (newly issued shares and cash), strategic rationale, and expected consolidation date (Q2 2021). This type of announcement, detailing a significant corporate transaction like an acquisition, falls under the category of Capital/Financing Update (CAP) as it directly relates to changes in the company's structure and financing through share issuance, or potentially Regulatory Filings (RNS) if it's a general disclosure. However, given the specific focus on the financing aspect (issuing shares as consideration) and the nature of the transaction, CAP is a strong fit. Since it is a formal announcement of a major corporate action involving capital structure changes (share issuance for acquisition), 'CAP' (Capital/Financing Update) is the most precise fit among the provided options, although 'RNS' is a possibility for general regulatory news. Given the explicit mention of issuing shares ('Vederlagsaktierna') as part of the consideration, CAP is preferred over the general RNS.
2021-05-19 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 1% confidence The document is a 'Delårsrapport' (Interim Report) for CELLINK AB for the period January–March 2021. It contains comprehensive financial statements, key performance indicators (EBITDA, net sales, gross margin), management commentary (VD-kommentar), and details on business operations and acquisitions. It is a full quarterly report, not an announcement or a summary. Q1 2021
2021-05-12 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report January-March 2021' for CELLINK AB. It contains comprehensive financial statements, including income statements, balance sheet data, key performance indicators (EBITDA, EBIT, net sales), and detailed management commentary on business performance, acquisitions, and market outlook for the specified quarterly period. It is not an announcement of a report, but the report itself, fitting the definition of an Interim/Quarterly Report. Q1 2021
2021-05-12 English
CELLINK meddelar ökning av antalet aktier och röster
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a press release dated April 30, 2021, titled "CELLINK meddelar ökning av antalet aktier och röster" (CELLINK announces increase in the number of shares and votes). It explicitly details the increase in the total number of outstanding shares (284,176 new shares issued via a directed share issue) and the resulting total share count and voting rights as of that date. This content directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). It is not a general regulatory filing (RNS) because it is highly specific to a capital event, nor is it a dividend notice (DIV) or director dealing (DIRS).
2021-04-30 Swedish
CELLINK announces an increase in number of shares and votes
Share Issue/Capital Change Classification · 1% confidence The document is a press release dated April 30, 2021, titled "CELLINK announces an increase in number of shares and votes." The text explicitly details that the increase is due to a directed new issue of shares carried out as part of financing for an acquisition. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). It is not an earnings release (ER), an interim report (IR), or a general regulatory filing (RNS), as it concerns a specific capital event.
2021-04-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.